Merdad Parsey - 10 Dec 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Edward S. Son by Power of Attorney for Merdad Parsey
Issuer symbol: GILD
Transactions as of: 10 Dec 2024
Net transactions value: -$163,534
Form type: 4
Filing time: 11 Dec 2024, 19:24:27 UTC
Previous filing: 29 Nov 2024
Next filing: 13 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+3,820	+4.7%		84,621	10 Dec 2024	Direct	F1
transaction	GILD	Common Stock	Tax liability	$163,534	-1,771	-2.1%	$92.34	82,850	10 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-3,820	-9.4%		36,753	10 Dec 2024	Common Stock	3,820		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.